| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |